
Programmable DNA drug destroying all cancers, unlocking 80% of targets
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers. FinalDose is a Y Combinator company (Spring 2026). YC-listed status: Active.